Pharmaceutical and cosmetic review – Scar treatment Oct 2015

Innovation that influences quality of life

Finding your niche in a highly competitive market is not easy. RégimA has done this successfully by continually driving innovation in a specific area of skin care – scar treatment. By Abby Vorster

Untitled-1R

 

égimA takes an agile approach to business, which favours continuous improvement. The company was launched in 1996 by its CEO, Jacqui Faucitt, who  is extremely passionate about solutions- orientated skin care. I recently had the pleasure of meeting Faucitt, and three things stood out for me about this enticing woman and her  business:RégimA takes an agile approach to business, which favours continuous improvement. The company was launched in 1996 by its CEO, Jacqui Faucitt, who  is extremely passionate about solutions- orientated skin care. I recently had the pleasure of meeting Faucitt, and three things stood out for me about this enticing woman and her  business:

More

RégimA Zone crowned in New Product Competition

regima range

Last night RégimA Skin Treatments’ Zone range took top prize as overall winner of the 2015 Pharmaceutical & Cosmetic Review/Symrise New Product Competition (NPC). The awards evening was held at Olives & Plates in Braamfontein, Johannesburg.

As part of the prize, a member of the RégimA team will be off to in-cosmetics 2016, a leading global business event for personal care ingredients. Next year’s show takes place from 12 to 14 April in Paris, France.

The results of the competition were as follows:

More

RégimA Zone – a truly targeted range of skin care products

RégimA Skin Treatments is a proudly South African brand of cosmeceuticals with a specialised focus on skin health and long-term aesthetics. The company is headed by CEO, Jacqui Faucitt, who is driven by the fundamental need to address serious skin concerns on the basis of delivering solutions that make a life-changing difference.

Age reversalRedefining skin care boundaries 

The company’s latest offering is RégimA Zone, recently launched in South Africa and London, which takes an entirely different look at product formulation. According to the company, the Zone draws a parallel to connect unsatisfied consumer needs and desires with emerging science and technology being developed by the collective innovation of global research and developments in skin care.

The central philosophy behind the new range is a paradigm shift from the existing norms. It attempts to address skin concerns and problems in terms of what is possible, rather than the common current approach of what is necessary.

Instead of pushing boundaries, the Zone attempts to redefine and reshape boundaries giving them greater affinity for improvement.

 

 

More

South Africans cautioned to increase their knowledge about sunscreen

sunscreenWhen protecting themselves from the sun, South Africans must not only pay attention to which type of sunscreen they use but also to how much they apply and how often.

This is the view of Dr Pete Vincent of the Netcare Travel Clinics and Medicross Family Medical and Dental Centre, Tokai, who is encouraging South Africans to become fully informed about sun protection to avoid developing melanoma and other types of skin cancer. Globally, South Africa ranks as having one of the highest, if not the highest, incidences of malignant melanoma, with people in the Cape being affected worst of all*.

According to the World Health Organization, approximately 66 000 deaths occur globally each year as a result of skin cancer. In a recent survey conducted amongst 1 500 female travellers from the United Kingdom, 22% stated they would not use sunscreen because they believed it was too expensive, that it did not work or that their skin did not burn.
‘What many of these people do not realise is that those who are exposed to the sun intermittently are more likely to develop malignant melanoma, while those who have continuous lifetime exposure are more prone to develop squamous cell carcinoma, which is also a type of skin cancer,’ explains Dr Vincent.
More